| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/19/2006 | EP1647596A2 Monoclonal antibody against platelet membrane glycoprotein vi |
| 04/19/2006 | EP1647281A2 Polynucleotide vaccine formula for treating horse diseases |
| 04/19/2006 | EP1646869A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/19/2006 | EP1646684A2 Polymer encapsulation of adenoviruses |
| 04/19/2006 | EP1646649A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors |
| 04/19/2006 | EP1646647A1 Babesia vaccines |
| 04/19/2006 | EP1646645A1 Antigenic peptides of sars coronavirus and uses thereof |
| 04/19/2006 | EP1646427A1 Cpg-packaged liposomes |
| 04/19/2006 | EP1646402A2 Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections |
| 04/19/2006 | EP1646401A2 Specific human antibodies |
| 04/19/2006 | EP1646400A1 Treatment of allergic diseases using a modulator of the notch signaling pathway |
| 04/19/2006 | EP1646282A1 Genetic vaccines for cancer therapy |
| 04/19/2006 | EP1373478B1 Attenuated live vaccine |
| 04/19/2006 | EP1210112B1 Vaccine against hbv and hpv |
| 04/19/2006 | EP1140161B1 Synthetic virus-like particles with heterologous epitopes |
| 04/19/2006 | EP1073760B1 Adenovirus mutants with deleted protease gene, complementing cell lines and corresponding vectors for gene transfer |
| 04/19/2006 | EP0912608B1 Choline binding proteins for anti-pneumococcal vaccines |
| 04/19/2006 | EP0789574B1 Use of naked polynucleotides in the manufacture of a medicament for treating tumours |
| 04/19/2006 | EP0778894B1 Infectious peritonitis vaccine |
| 04/19/2006 | CN1761756A Depletion of endogenous primordial germ cells in avian species |
| 04/19/2006 | CN1761750A Glycorpotein antigen SIMA135 expressed in metastatic human tumor cells |
| 04/19/2006 | CN1761745A A novel human virus causing severe acute respiratory syndrome (SARS) and uses thereof |
| 04/19/2006 | CN1761744A Cultured CD14+ antigen presenting cells |
| 04/19/2006 | CN1761683A Cancerous disease modifying antibodies |
| 04/19/2006 | CN1761484A A method of diagnosis and treatment |
| 04/19/2006 | CN1761483A Modified free-living microbes, vaccine compositions and methods of use thereof |
| 04/19/2006 | CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 04/19/2006 | CN1761477A Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 04/19/2006 | CN1760209A Interfusion protein of human interleukin 15 and Fe |
| 04/19/2006 | CN1759886A Live vaccine (CC gene stock) of cytokine adjuvant in animal immunopotentiator for treating chicken new castle disease |
| 04/19/2006 | CN1252264C Inhibition of viral infection using monovalent antigen-binding proteins |
| 04/19/2006 | CN1252130C Hydrophilic polymer and tanshinones medicine conjugation agent and medicine composition containing same |
| 04/19/2006 | CN1252087C Tetramer combined with SARS antigen peptide and its preparation and use |
| 04/19/2006 | CN1251762C Heat resisting lyophilized protectant for chicken infections Fabianite bursa hypotpxicity (B87) lyophilized vaccine and preparing process thereof |
| 04/19/2006 | CN1251761C Vaccine comprising cytokine-induced heat shock proteins |
| 04/18/2006 | US7030234 Non-M, non-O HIV-1 strains, fragments and uses |
| 04/18/2006 | US7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
| 04/18/2006 | US7030222 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030212 Tumor antigen based on products of the tumor suppressor gene WT1 |
| 04/18/2006 | US7030211 Antigenic peptides derived from telomerase |
| 04/18/2006 | US7030101 A beta-glucan and specific antibodies, such as antibodies specific to Staphylococcus Type 5 antigen or Type 8 antigen; IGIV (immune globulin intravenous) |
| 04/18/2006 | US7030098 DNA vaccination for treatment of autoimmune disease |
| 04/18/2006 | US7030094 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
| 04/18/2006 | US7029903 Cold-adapted equine influenza viruses |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029859 Sequences for targeting metastatic cells |
| 04/18/2006 | US7029845 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses |
| 04/18/2006 | US7029708 Herbal supplement for cognitive related impairment due to estrogen loss |
| 04/18/2006 | US7029686 Variants of Phleum pratense allergenic proteins |
| 04/18/2006 | US7029685 Plasmodium falciparum AMA-1 protein and uses thereof |
| 04/18/2006 | US7029684 Antigenic composition of a Pseudomonas aeruginosa |
| 04/18/2006 | US7029683 Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
| 04/18/2006 | US7029682 Immunogenic preparation that is recognized as a specific monoclonal antibody and a veterinarily acceptable vehicle or excipient |
| 04/18/2006 | US7029681 Multiple and multivalent DNA vaccines in ovo |
| 04/18/2006 | US7029680 Delivery of immunogenic molecules vis HBsAg particles |
| 04/18/2006 | US7029679 Variant of LAV viruses |
| 04/18/2006 | US7029678 Vaccines |
| 04/18/2006 | US7029677 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 04/18/2006 | US7029675 administering hepsin blocking peptides with a specific amino acid sequence that reduce infarction volume by inactivating or suppressing gene expression of hepsin |
| 04/18/2006 | US7029674 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 04/18/2006 | CA2268825C Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/18/2006 | CA2252505C New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 04/18/2006 | CA2173601C Liposomes containing particulate materials |
| 04/13/2006 | WO2006039659A1 Bioadhesive delivery system for transmucosal delivery of beneficial agents |
| 04/13/2006 | WO2006039652A2 Chondroitin sulfate a binding domains |
| 04/13/2006 | WO2006039644A2 Methods of treating cd30 positive lymphomas |
| 04/13/2006 | WO2006039631A2 Methods and compositions for treating renal cell carcinoma related pathologies |
| 04/13/2006 | WO2006039470A2 Anti- amyloid antibodies, compositions, methods and uses |
| 04/13/2006 | WO2006039418A2 Human monoclonal antibodies to fc gamma receptor ii (cd32) |
| 04/13/2006 | WO2006039135A2 Irta-4 antibodies and their uses |
| 04/13/2006 | WO2006038742A1 Recombinant virus and use thereof |
| 04/13/2006 | WO2006038729A1 Mutated amyloid protein |
| 04/13/2006 | WO2006038124A1 Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection |
| 04/13/2006 | WO2006038115A1 Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 04/13/2006 | WO2006037807A2 Identification of regions of apical membrane antigen 1 of apicomplexan parasites suitable for targeting by vaccines and drugs by derivation and analysis of the three-dimensional structure |
| 04/13/2006 | WO2006037658A1 Combination vaccine |
| 04/13/2006 | WO2006037604A1 Novel antibodies directed to the mammalian eag1 ion channel protein |
| 04/13/2006 | WO2006037421A2 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 04/13/2006 | WO2006037383A1 Piscirickettsia salmonis antigens and use thereof |
| 04/13/2006 | WO2006037247A1 Type i interferon blocking agents for prevention and treatment of psoriasis |
| 04/13/2006 | WO2006037229A1 Formulation of multivalent antibody constructs and use of same for cancer therapy |
| 04/13/2006 | WO2006012373A3 Combination therapies of hmgb and complement inhibitors against inflammation |
| 04/13/2006 | WO2006010515A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 04/13/2006 | WO2006006074A3 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 04/13/2006 | WO2005113607A3 Measuring degree of polymerisation for capsular saccharides that contain sialic acid |
| 04/13/2006 | WO2005112997A3 Composition and method for introduction of dna directed or direct rna interference sequence into targeted cells and tissues |
| 04/13/2006 | WO2005110471A3 Preparation of salmonella broad-spectrum vaccines |
| 04/13/2006 | WO2005105139A3 Mage-3 and ny-eso-1 based polyvalent vaccine for cancer immunotherapy |
| 04/13/2006 | WO2005090986A3 Analysis of saccharide vaccines without interference |
| 04/13/2006 | WO2005077411A3 Composition and method for the treatment of carcinoma |
| 04/13/2006 | WO2005074983A3 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
| 04/13/2006 | WO2005072479A3 Polymer-bound antibody concer therapeutic agent |
| 04/13/2006 | WO2005062820A3 Multi plasmid system for the production of influenza virus |
| 04/13/2006 | WO2005060328A3 ENCODING NUCLEOTIDES OF GENES FROM THE CHROMOSOME OF THE BACTERIUM Mycoplasma hyopneumoniae, EXPRESSION AND ACTIVITY OF THE POLYNUCLEOTIDES AND THEIR APPLICATIONS |
| 04/13/2006 | WO2005051455A3 Ultrasound assisted transdermal vaccine delivery method and system |
| 04/13/2006 | WO2005032460A3 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/13/2006 | US20060079495 Diagnosis and treatment system for "reward deficiency syndrome" (RDS) and related behaviors |
| 04/13/2006 | US20060079470 Combined dna vaccine and biological modifiers for cancer therapy |
| 04/13/2006 | US20060079453 Hla binding peptides and their uses |